GLP-1s for Employers: Navigating What’s Next

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

GLP-1s for Employers: Navigating What’s Next

Listen for free

View show details

About this listen

This week on The Granite List.Live, Sally is joined by Jessica Lea, PharmD and CEO of Tria Health, as they dive into the fast-changing landscape of GLP-1 medications for obesity and diabetes. Jessica shares her insight on why pharmacist-led oversight is important, especially with complex and costly drugs like Ozempic and Wegovy. Additionally, together, Sally and Jessica explore:

Challenges employers face when deciding whether to cover these medications
The impact of direct-to-consumer options
The importance of combining medication with lifestyle changes for lasting results
Future developments in GLP-1 treatments and their potential uses.

Learn more about Tria Health on The Granite List!

No reviews yet